Description: VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA).
CAS Number: 745833-23-2
Formula: C19H12F4N4O2
Molecular Weight: 404,32
References: Kuliopulos A, et al. Thromb Haemost, 2004, 92(6), 1387-1393.